Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Jul 12;6(3):281-289.
doi: 10.1002/agm2.12260. eCollection 2023 Sep.

Temporal patterns of the burden of Alzheimer's disease and their association with Sociodemographic Index in countries with varying rates of aging 1990-2019

Affiliations

Temporal patterns of the burden of Alzheimer's disease and their association with Sociodemographic Index in countries with varying rates of aging 1990-2019

Majed Ramadan. Aging Med (Milton). .

Abstract

Objective: To we examine the temporal patterns of the burden of Alzheimer's disease and their association with Sociodemographic Index in countries with varying rates of aging.

Method: Data were obtained from Global Burden of Diseases studies (GBD) 2019 and were used to compare countries with different rates of change in aging population from 1990 to 2019. We collected the data of the age-standardized rates per 100,000 of disability-adjusted life years (DALYs), incidence, prevalence of Alzheimer's disease and other dementias, and the age-specific population rates per 100,000.

Results: Countries with high rates of change in their aging populations had an increase in DALYs, incidence, and prevalence of Alzheimer's disease and other dementias over the last 30 years. Countries with a high rate of change in aging population had a significantly positive association among DALYs, incidence, and prevalence of Alzheimer's disease and other dementias. In contrast, countries with a medium and low rate of change in aging population had negative associations between DALYs and incidence of Alzheimer's disease and other dementias.

Conclusion: This study highlights the significant impact of demographic changes on the burden, prevalence, and incidence of Alzheimer's disease and other dementia. The study also found that robust health care and social systems, as reflected by a higher Sociodemographic Index, can contribute to reducing the burden of Alzheimer's disease and other dementias in medium to low rates of aging populations. The findings underscore the importance of investing in health care and social systems to address the growing burden of these conditions, especially in countries with a high rate of change in the aging population.

Keywords: Alzheimer's disease; Sociodemographic Index (SDI); aging; disability‐adjusted life years (DALY).

PubMed Disclaimer

Conflict of interest statement

The author declares that he has no competing interests.

Figures

FIGURE 1
FIGURE 1
DALY Alzheimer's disease and other dementias.
FIGURE 2
FIGURE 2
Temporal trends in incidence and prevalence of Alzheimer's disease among diverse aging populations from 1990 to 2019.

References

    1. Gate D, Tapp E, Leventhal O, et al. CD4+ T cells contribute to neurodegeneration in Lewy body dementia. Science. 2021;374(6569):868‐874. doi:10.1126/science.abf7266 - DOI - PMC - PubMed
    1. Lyketsos CG, Carrillo MC, Ryan JM, et al. Neuropsychiatric symptoms in Alzheimer's disease. Alzheimers Dement. 2011;7(5):532‐539. doi:10.1016/j.jalz.2011.05.2410 - DOI - PMC - PubMed
    1. Srivastava S, Ahmad R, Khare SK. Alzheimer's disease and its treatment by different approaches: a review. Eur J med Chem. 2021;15(216):113320. doi:10.1016/j.ejmech.2021.113320 - DOI - PubMed
    1. Guerchet M, Prince M, Prina M. Numbers of people with dementia worldwide: an update to the estimates in the World Alzheimer Report. 2015.
    1. Nichols E, Szoeke CE, Vollset SE, et al. Global, regional, and national burden of Alzheimer's disease and other dementias, 1990–2016: a systematic analysis for the global burden of disease study 2016. Lancet Neurol. 2019;18(1):88‐106. doi:10.1016/S1474-4422(18)30403-4 - DOI - PMC - PubMed